Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses South Korea10-2017-7000999Filed on 2015-07-17
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Japan2017-502693Filed on 2015-07-17
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses India201717003787Filed on 2015-07-17
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Israel249671Filed on 2015-07-17
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses European Patent15821743.0Filed on 2015-07-17
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses China201580038799.6Filed on 2015-07-17
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Canada2955432Filed on 2015-07-17
Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Read more about Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses Australia2015289449Filed on 2015-07-17
Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Read more about Human Monoclonal Antibodies Specific For Glypican-3 And Use Thereof Hong Kong17102681.1Filed on 2017-03-15
AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Sweden07838099.5Filed on 2007-09-13